Last reviewed · How we verify
NCT07168863: EUS-PANCREA
EUS-guided FNB-induced PANCREatitis Assessment
trial testing EUS-guided FNB in Pancreatitis, Acute in 300 participants. Currently enrolling.
12 February 2027
Quick facts
| Lead sponsor | University of Tehran |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 11 September 2025 |
| Primary completion | 12 February 2027 |
| Estimated completion | 12 March 2027 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- EUS-guided FNB
Conditions studied
- Pancreatitis, Acute — all drugs for Pancreatitis, Acute →
- EUS Guided Biopsy — all drugs for EUS Guided Biopsy →
Sponsor
University of Tehran
Who can join
18 and older, any sex, with Pancreatitis, Acute or EUS Guided Biopsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a descriptive analytical study to investigate the prevalence and risk factors for pancreatitis after Endoscopic Ultrasonography-guided Fine Needle Biopsy (EUS-FNB) in patients at Shariati Hospital in Tehran. The study aims to identify risk factors for post-FNB pancreatitis to improve clinical protocols, reduce complications and treatment costs, and increase diagnostic accuracy for pancreatic and biliary tract diseases. The study will collect demographic and clinical data from all eligible patients undergoing EUS-guided FNB during the study period. Amylase and lipase levels will be measured in all enrolled patients 24 hours post-procedure. Pancreatitis will be diagnosed based on abdominal pain and amylase or lipase levels exceeding three times the normal range 24 hours after the procedure. The outcomes will be independently adjudicated by an expert gastroenterologist not involved in the EUS procedures by reviewing participants' medical records. The consensus definition will be applied as a diagnostic framework (rather than a strict definition) so that the adjudicator can use their best judgment in cases that does not strictly satisfy the criteria. The patients will be contacted 24-72 h after the procedure to follow-up on any potential complications. The study plans to enroll at least 300 patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07168863
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pancreatitis, Acute
Currently open trials in the same condition.
- NCT07267169 — Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis · NA · recruiting
- NCT07244432 — Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS) · recruiting
- NCT07171112 — Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis · Phase 2 · recruiting
- NCT07202559 — Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Sho · NA · recruiting
- NCT06729996 — Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus · Phase 2 · recruiting
Other University of Tehran trials
Trials by the same sponsor.
- NCT05530772 — Immediate vs. On-demand Endoscopic Necrosectomy in Infected Walled-off Pancreatic Necrosis · NA · completed
- NCT05569902 — tACS Improves Memory in Elders With Subjective Memory Complaints · NA · completed
- NCT06030024 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder · NA · completed
- NCT04975620 — Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass Lesions · NA · completed
- NCT03468686 — The Study of Effectiveness of rTMS on Rumination and Anhedonia in Patients With Major Depressive Disorder · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07168863 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tehran
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07168863.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing